The Effects of Low-level Laser Therapy in Extensor Tendon Injuries Between Zones 5-8

June 15, 2022 updated by: faruk erdogan, Turkish League Against Rheumatism

The Effects of Low-level Laser Therapy in Extensor Tendon Injuries Between Zones 5-8: A Randomized Controlled Trial

This study examines the rehabilitation results when low-level laser therapy is applied in zone 5-8 extensor tendon injuries. Rehabilitation results will be evaluated with both objective measurements and patient reported outcome measures. The study was planned as a double-blind, placebo-controlled, randomized, two-arm study. Participants in both treatment groups will be given exercise therapy in accordance with the early active mobilization protocol and appropriate splint will be given to be used while exercising.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

55

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ankara, Turkey, 06800
        • Ankara City Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 63 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Being between the ages of 18-65
  • Primary repair due to extensor tendon injury between Zones V-VIII
  • Applying to the Hand Rehabilitation Policlinic at the end of the postoperative 1st week

Exclusion Criteria:

  • Accompanying flexor tendon injury, fracture, vascular and / or nerve injury
  • Active using of steroids or non-steroidal anti-inflammatory drugs
  • Systemic infection or malignancy
  • Pregnant or breastfeeding women
  • Active wound infection
  • Having a cognitive dysfunction

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Treatment group of low level laser therapy
We will use laser light that has continuous wave mode, power of 100 mW, energy density of 7,5 joule/cm2, treatment time as 300 seconds.
Other Names:
  • Sham laser therapy
Placebo Comparator: Sham group of low level laser therapy
We will use laser light that has continuous wave mode, power of 100 mW, energy density of 7,5 joule/cm2, treatment time as 300 seconds.
Other Names:
  • Sham laser therapy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in total active motion degrees
Time Frame: Pre-intervention, immediately after the intervention, eighth week
The difference of active range of motion (ROM) measurements between injured and non-injured digit(s). ROM measurement will be made with the help of a standard hand goniometer and the measured degree will be recorded.
Pre-intervention, immediately after the intervention, eighth week
Grip strength
Time Frame: Eighth week
Grip strength measurement will be made with the Jamar dynamometer. The measured value will be recorded in kilograms.
Eighth week
Change in visual analog scale (VAS) score
Time Frame: Pre-intervention, immediately after the intervention, eighth week
VAS is a scale used to assess pain. Minimum value of the scale is 0 and maximum is 10. Higher scores mean a worse outcome.
Pre-intervention, immediately after the intervention, eighth week
Change in metacarpophalangeal joint circumference
Time Frame: Pre-intervention, immediately after the intervention, eighth week
It will be used to evaluate edema in the dorsum of the hand. Measurement will be made with the help of a tape measure. The measured value will be recorded in milimeters.
Pre-intervention, immediately after the intervention, eighth week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in quick disabilities of arm, shoulder and hand (QuickDASH) score
Time Frame: Pre-intervention, immediately after the intervention, eighth week
A scale used for measuring physical function and symptoms of upper extremities. Minimum value of the scale is 0 and maximum is 100. Higher scores mean a worse outcome.
Pre-intervention, immediately after the intervention, eighth week
Change in short form-36 (SF-36) scores
Time Frame: Pre-intervention, immediately after the intervention, eighth week
A scale used for determining quality of life. This form evaluates the quality of life under 9 different headings. Minimum value of all headings is %0 and maximum is %100. Higher scores mean a better outcome.
Pre-intervention, immediately after the intervention, eighth week
Return to work
Time Frame: Eighth week
The rehabilitation period required for patients to return to work
Eighth week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 30, 2020

Primary Completion (Actual)

December 30, 2020

Study Completion (Actual)

December 30, 2020

Study Registration Dates

First Submitted

January 27, 2021

First Submitted That Met QC Criteria

February 2, 2021

First Posted (Actual)

February 8, 2021

Study Record Updates

Last Update Posted (Actual)

June 21, 2022

Last Update Submitted That Met QC Criteria

June 15, 2022

Last Verified

June 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • TRASD-FE-TEZ

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Tendon Injury - Hand

Clinical Trials on low level laser therapy

3
Subscribe